Approvals/TGA/QDENGA dengue tetravalent vaccine (live, attenuated) dengue virus serotypes 1, 2, 3, and 4, powder (vial) & solvent (vial) for injection

Approved

STANDARD

QDENGA dengue tetravalent vaccine (live, attenuated) dengue virus serotypes 1, 2, 3, and 4, powder (vial) & solvent (vial) for injection

Takeda Pharmaceuticals Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Date: Apr 12, 2026
Approval ID: 310e02c5edf384e5
Company: Takeda Pharmaceuticals Australia Pty Ltd
Type: Standard

Approval Details

Approval Id: 310e02c5edf384e5
Product Name: QDENGA dengue tetravalent vaccine (live, attenuated) dengue virus serotypes 1, 2, 3, and 4, powder (vial) & solvent (vial) for injection
Artg Id: 484846
Artg Name: QDENGA dengue tetravalent vaccine (live, attenuated) dengue virus serotypes 1, 2, 3, and 4, powder (vial) & solvent (vial) for injection
Sponsor: Takeda Pharmaceuticals Australia Pty Ltd
Company Detail Path: /organization/319c36b75d1bae7c/takeda-pharmaceuticals-australia-pty-ltd
Artg Date: 2026-04-08
Registration Type: Medicine
Therapeutic Good Type: Medicines
Licence Status: A
Licence Category: RE

Approved

Quick Info

Agency

TGA

Country

🇦🇺

Approval Date

Apr 12, 2026

Approval ID

310e02c5edf384e5

Type

Standard

Back to TGA Approvals